ArriVent BioPharma Enters Exclusive License with Lepu Biopharma for MRG007
22 Jan 2025 //
PRESS RELEASE
DP Technology & Lepu Bio Collaborate to Accelerate ADC Innovation
21 Nov 2024 //
PR NEWSWIRE
Keymed, Lepu Enter Global License Agreement with AstraZeneca for CMG901
23 Feb 2023 //
CONTRACT PHARMA
Keymed and Lepu Jointly Announce Agreement with AZ for CMG901
22 Feb 2023 //
PR NEWSWIRE
Chime Biologics Receives Commercial Manufacturing License
02 Aug 2022 //
CONTRACTPHARMA